P3-087: Phase II trial of sequenced bevacizumab and erlotinib with bevacizumab and chemotherapy for 1st line stage IIIB or IV Non-small cell lung cancer (NSCLC)

Authors :: Julie Schwegman
Ramaswamy Govindan
Philip C. Hoffman
Everett E. Vokes
Livia Szeto
Ann M. Mauer
Mark Kozloff
Ezra E.W. Cohen
Theodore Karrison
Ravi Salgia
Source :: Journal of Thoracic Oncology. (8):S716
Publisher :: International Association for the Study of Lung Cancer. Published by Elsevier Inc.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
Chemotherapy
medicine.medical_specialty
Bevacizumab
business.industry
medicine.medical_treatment
non-small cell lung cancer (NSCLC)
Stage iiib
medicine.disease
respiratory tract diseases
Internal medicine
medicine
Erlotinib
Line (text file)
business
neoplasms
medicine.drug

Full Text Access

Tools